Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07011420 · ClinicalTrials.gov registry record · NA
Effects of Myoelectric Channel Count and Targeting for Upper Limb Prosthetic Control
A NA study of Amputation and Prosthesis User, sponsored by Liberating Technologies.
- Recruiting
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 2
- Study locations
NCT07011420: Recruiting NA study of Amputation and Prosthesis User, sponsored by Liberating Technologies.
NCT07011420 is a NA study of Amputation and Prosthesis User that is actively recruiting participants, run by Liberating Technologies. The registered enrollment target is 32 participants, below the 132-participant average among 65 other Amputation trials with a reported enrollment target (76% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07011420, a NA study of Amputation and Prosthesis User, is actively recruiting participants, sponsored by Liberating Technologies.
- RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to systematically evaluate whether or not two commonly held fundamental assumptions for pattern recognition control translates to functional performance when tested on individuals aged 18 years or older with upper limb absence at the transradial level while wearing a physical prosthesis. The specific aims of this study are: 1. To evaluate the effect of changing untargeted myoelectric channel count on the functional performance of transradial prosthesis users wearing a fully functional prosthesis via functional outcomes measures such as the Box and Blocks test. 2. To evaluate the effect of changing myoelectric channel targeting of a fixed number of myoelectric channels on the functional performance of transradial prosthesis users wearing a fully functional prosthesis via functional outcomes measures such as the Box and Blocks test. Researchers will perform a randomized crossover study to compare system configurations with different number of sensor channels and with various strategies for sensor placement on the limb. Participants will be assigned to a random test sequence that includes the following four different EMG channel conditions: Condition A: 4 untargeted channels Condition B: 8 untargeted channels Condition C: Up to 16 untargeted channels Condition D: 8 targeted channels Researchers will evaluate the effects of changing myoelectric channel counts on the functional prosthesis performance of individuals with transradial limb loss via functional outcome measures. Participants will: * Attend up to 5 in-lab sessions that are expected to last 4 hours. * Conduct site visits every 1-2 weeks to complete functional and self reported outcome measures with each condition. * Play virtual games with the Coapt Cuff for 15 minutes a day, 3 days a week in between visits.
Primary Outcome
The ACMC is a performance-based assessment where trained raters observe the user performing a task and rate their ability to control specific hand movements. These movements are rated on a 4-point scale, ranging from "not capable" to "spontaneously capable". 0 = Not capable. 1 = Sometimes capable, capacity not established. 2 = Capable on request. 3 = Spontaneously capable. The items comprising the ACMC describe different levels of difficulty of control of the myoelectric hand. The items are gro
Conditions Studied
Interventions
- DEVICE Experimental socket with 4 untargeted channels active
- DEVICE Experimental socket with 8 untargeted channels active
- DEVICE Experimental socket with up to 16 untargeted channels active
- DEVICE Experimental socket with 8 targeted channels active
- DEVICE Coapt EMG Cuff
Study Locations (2)
Illinois
- Shirley Ryan AbilityLab - Chicago
Massachusetts
- Liberating Technologies, Inc. - Holliston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2025-10 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT07011420 shows while recruiting
NCT07011420 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 132-participant average among 65 other Amputation trials with a reported enrollment target (76% lower).
The record links to 6 conditions, with Amputation appearing as the primary indexed condition, and to 5 interventions - of which Experimental socket with 4 untargeted channels active is the first listed.
NCT07011420 reports a single indexed study location in Illinois, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07011420 about?
NCT07011420 is a clinical study titled "Effects of Myoelectric Channel Count and Targeting for Upper Limb Prosthetic Control". The goal of this clinical trial is to systematically evaluate whether or not two commonly held fundamental assumptions for pattern recognition control translates to functional performance when tested on individuals aged 18 years or older with upper limb absence at the transradial level while wearing...
What is the current status of trial NCT07011420?
This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2025-10. Estimated completion is 2026-06.
What conditions does trial NCT07011420 study?
This clinical trial studies the following conditions: Amputation, Prosthesis User, Amputation, Traumatic, Upper Limb Amputation Below Elbow (Injury), Amputation, Congenital.
What interventions are being tested in trial NCT07011420?
The interventions under investigation include: Experimental socket with 4 untargeted channels active (DEVICE), Experimental socket with 8 untargeted channels active (DEVICE), Experimental socket with up to 16 untargeted channels active (DEVICE), Experimental socket with 8 targeted channels active (DEVICE), Coapt EMG Cuff (DEVICE).
Who is sponsoring clinical trial NCT07011420?
This trial is sponsored by Liberating Technologies, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07011420 being conducted?
This trial has 2 study locations across Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amputation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07011420's enrollment target sits among peer trials
32 27th of 65 higher than 38 of 65 other Amputation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amputation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Myoelectric Implantable Recording Array (MIRA) in Participants With Transradial Amputation
RECRUITING · NA
-
Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain.Home-Based Treatment
RECRUITING · NA
-
Hand Transplantation
RECRUITING · NA
-
Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of Residual and Phantom Limb Pain in Cancer Patients Who Have Received an Amputation
RECRUITING · NA
-
Can an Array of Micro-electrodes Implanted in a Human Nerve Record Neural Signals and Provide Feedback?
RECRUITING · NA
-
Intuitive Control of a Hybrid Prosthetic Leg During Ambulation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia